ALAMEDA, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) and NBE-Therapeutics today announced a partnership to discover and develop multiple antibody-drug conjugates (ADCs) ...
The National Board of Examinations (NBE) has declared the results of the Fellowship Entrance Test (FET 2023). Candidates who appeared for the exam can download their results from the official website ...
Banque Misr and the National Bank of Egypt have raised the interest rate on a new triple savings certificate from 18.5 percent to 19.5 percent. Triple Savings Certificate from the National Bank of ...
Boehringer Ingelheim is pumping funds into the still-hot antibody-drug conjugate space, committing 27 million Swiss francs ($31.06 million) to a new R&D facility specifically focused on the modality.
- Agreement encompasses an exclusive option on multiple targets over a two-year term, with potential to extend time and scope of the collaboration - “NBE-Therapeutics’ technology platforms give drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results